UBC Medical Indonesia Tbk. vs Tianrong Chemicals Industry Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Tianrong Chemicals Industry Tbk. trades at Rp119 (market cap 1.25T). The key difference: Tianrong Chemicals Industry Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| LABS | TDPM | |
|---|---|---|
Market Cap | 691.25B | 1.25T |
Volume | 635.5K | — |
Lot | 6.36K | — |
Turnover | 110.15M | — |
Average Price | 173.33 | — |
Value | 110.15M | — |
Indicative Equilibrium Price | 174 | — |
Indicative Equilibrium Volume | 50 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Tridomain Performance Materials (previously PT Royal Chemie Indonesia) (the "Company”) was established on December 16, 2003 under the framework of the Foreign Capital Investment Law No. 1 Year 1967 (as amended by Law No. 11 Year 1970) based on the notarial deed No. 51 of Veronica Nataadmadja, S.H., Notary in Jakarta.
Read more on TDPM →